Motilal Oswal S&P BSE Healthcare ETF

Fund Overview

Fund Size

₹26 Cr

Expense Ratio

0.22%

ISIN

INF247L01BB1

Minimum SIP

Exit Load

Inception Date

29 Jul 2022

About this fund

Motilal Oswal S&P BSE Healthcare ETF is a Sector - Healthcare mutual fund schemes offered by Motilal Oswal Mutual Fund. This fund has been in existence for 2 years, 7 months and 28 days, having been launched on 29-Jul-22.
As of 27-Mar-25, it has a Net Asset Value (NAV) of ₹41.86, Assets Under Management (AUM) of 25.63 Crores, and an expense ratio of 0.22%.

Motilal Oswal S&P BSE Healthcare ETF has given a CAGR return of 25.44% since inception.
The fund's asset allocation comprises around 99.79% in equities, 0.00% in debts, and 0.21% in cash & cash equivalents.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+19.97%

+17.95% (Cat Avg.)

Since Inception

+25.44%

— (Cat Avg.)

Portfolio Summaryas of 28th February 2025

Equity	₹25.57 Cr	99.79%
Others	₹0.05 Cr	0.21%

Top Holdings

All Holdings

Equity

Debt & Others

Name	Type	Amount	Holdings
Sun Pharmaceuticals Industries Ltd	Equity	₹3.92 Cr	15.30%
Cipla Ltd	Equity	₹1.79 Cr	6.99%
Max Healthcare Institute Ltd Ordinary Shares	Equity	₹1.65 Cr	6.43%
Divi's Laboratories Ltd	Equity	₹1.59 Cr	6.21%
Dr Reddy's Laboratories Ltd	Equity	₹1.55 Cr	6.05%
Apollo Hospitals Enterprise Ltd	Equity	₹1.39 Cr	5.42%
Lupin Ltd	Equity	₹1.05 Cr	4.10%
Fortis Healthcare Ltd	Equity	₹0.72 Cr	2.83%
Aurobindo Pharma Ltd	Equity	₹0.67 Cr	2.62%
Torrent Pharmaceuticals Ltd	Equity	₹0.64 Cr	2.48%
Alkem Laboratories Ltd	Equity	₹0.56 Cr	2.17%
Mankind Pharma Ltd	Equity	₹0.52 Cr	2.04%
Zydus Lifesciences Ltd	Equity	₹0.5 Cr	1.96%
Laurus Labs Ltd	Equity	₹0.47 Cr	1.85%
Glenmark Pharmaceuticals Ltd	Equity	₹0.44 Cr	1.70%
Ipca Laboratories Ltd	Equity	₹0.41 Cr	1.62%
Abbott India Ltd	Equity	₹0.35 Cr	1.38%
Suven Pharmaceuticals Ltd	Equity	₹0.35 Cr	1.38%
Biocon Ltd	Equity	₹0.31 Cr	1.20%
Krishna Institute of Medical Sciences Ltd	Equity	₹0.29 Cr	1.13%
Gland Pharma Ltd	Equity	₹0.28 Cr	1.09%
Syngene International Ltd	Equity	₹0.27 Cr	1.05%
J.B. Chemicals & Pharmaceuticals Ltd	Equity	₹0.27 Cr	1.05%
Piramal Pharma Ltd	Equity	₹0.26 Cr	1.03%
Ajanta Pharma Ltd	Equity	₹0.24 Cr	0.94%
GlaxoSmithKline Pharmaceuticals Ltd	Equity	₹0.23 Cr	0.89%
Narayana Hrudayalaya Ltd	Equity	₹0.22 Cr	0.87%
Global Health Ltd	Equity	₹0.22 Cr	0.85%
Neuland Laboratories Limited	Equity	₹0.21 Cr	0.81%
Wockhardt Ltd	Equity	₹0.21 Cr	0.80%
Aster DM Healthcare Ltd Ordinary Shares	Equity	₹0.2 Cr	0.79%
Concord Biotech Ltd	Equity	₹0.2 Cr	0.78%
Dr. Lal PathLabs Ltd	Equity	₹0.2 Cr	0.77%
Poly Medicure Ltd	Equity	₹0.17 Cr	0.68%
Natco Pharma Ltd	Equity	₹0.16 Cr	0.61%
Jubilant Pharmova Ltd	Equity	₹0.16 Cr	0.61%
Granules India Ltd	Equity	₹0.15 Cr	0.60%
Rainbow Childrens Medicare Ltd	Equity	₹0.14 Cr	0.56%
Pfizer Ltd	Equity	₹0.14 Cr	0.54%
Jupiter Life Line Hospitals Ltd	Equity	₹0.12 Cr	0.48%
Ami Organics Ltd	Equity	₹0.12 Cr	0.46%
Eris Lifesciences Ltd Registered Shs	Equity	₹0.11 Cr	0.44%
Sanofi India Ltd	Equity	₹0.1 Cr	0.40%
Vijaya Diagnostic Centre Ltd	Equity	₹0.1 Cr	0.38%
Strides Pharma Science Ltd	Equity	₹0.1 Cr	0.38%
AstraZeneca Pharma India Ltd	Equity	₹0.1 Cr	0.37%
Marksans Pharma Ltd	Equity	₹0.1 Cr	0.37%
Metropolis Healthcare Ltd	Equity	₹0.09 Cr	0.37%
Alembic Pharmaceuticals Ltd	Equity	₹0.09 Cr	0.36%
Procter & Gamble Health Ltd	Equity	₹0.09 Cr	0.35%
Caplin Point Laboratories Ltd	Equity	₹0.09 Cr	0.33%
Aarti Pharmalabs Ltd	Equity	₹0.08 Cr	0.32%
Shilpa Medicare Ltd	Equity	₹0.07 Cr	0.29%
Alivus Life Sciences Ltd	Equity	₹0.06 Cr	0.24%
Kovai Medical Center & Hospital Ltd	Equity	₹0.06 Cr	0.22%
Indegene Ltd	Equity	₹0.06 Cr	0.22%
Net Receivables / (Payables)	Cash	₹0.05 Cr	0.21%
HealthCare Global Enterprises Ltd	Equity	₹0.05 Cr	0.18%
FDC Ltd	Equity	₹0.04 Cr	0.17%
Blue Jet Healthcare Ltd	Equity	₹0.04 Cr	0.16%
Sequent Scientific Ltd	Equity	₹0.04 Cr	0.16%
Morepen Laboratories Ltd	Equity	₹0.04 Cr	0.14%
Indraprastha Medical Corp Ltd	Equity	₹0.04 Cr	0.14%
Supriya Lifescience Ltd	Equity	₹0.04 Cr	0.14%
Orchid Pharma Ltd	Equity	₹0.03 Cr	0.13%
Solara Active Pharma Sciences Ltd Ordinary Shares	Equity	₹0.03 Cr	0.12%
Hikal Ltd	Equity	₹0.03 Cr	0.12%
Dishman Carbogen Amics Ltd	Equity	₹0.03 Cr	0.11%
Krsnaa Diagnostics Ltd	Equity	₹0.03 Cr	0.11%
Advanced Enzyme Technologies Ltd	Equity	₹0.03 Cr	0.11%
Unichem Laboratories Ltd	Equity	₹0.03 Cr	0.11%
Aarti Drugs Ltd	Equity	₹0.03 Cr	0.11%
Sun Pharma Advanced Research Co Ltd	Equity	₹0.03 Cr	0.10%
Innova Captab Ltd	Equity	₹0.03 Cr	0.10%
Thyrocare Technologies Ltd	Equity	₹0.02 Cr	0.09%
Yatharth Hospital and Trauma Care Services Ltd	Equity	₹0.02 Cr	0.09%
RPG Life Sciences Ltd	Equity	₹0.02 Cr	0.08%
Gufic Biosciences Ltd	Equity	₹0.02 Cr	0.08%
Bliss GVS Pharma Ltd	Equity	₹0.02 Cr	0.07%
Indoco Remedies Ltd	Equity	₹0.02 Cr	0.07%
Syncom Formulation (India) Ltd	Equity	₹0.02 Cr	0.06%
IOL Chemicals And Pharmaceuticals Ltd	Equity	₹0.02 Cr	0.06%
Gujarat Themis Biosyn Ltd	Equity	₹0.02 Cr	0.06%
Artemis Medicare Services Ltd Ordinary Shares	Equity	₹0.02 Cr	0.06%
Sigachi Industries Ltd	Equity	₹0.02 Cr	0.06%
Suven Life Sciences Ltd	Equity	₹0.02 Cr	0.06%
Vimta Labs Ltd	Equity	₹0.01 Cr	0.06%
Windlas Biotech Ltd	Equity	₹0.01 Cr	0.05%
Hester Biosciences Ltd	Equity	₹0.01 Cr	0.05%
SMS Pharmaceuticals Ltd	Equity	₹0.01 Cr	0.05%
Novartis India Ltd	Equity	₹0.01 Cr	0.05%
Shalby Ltd	Equity	₹0.01 Cr	0.05%
Lincoln Pharmaceuticals Ltd	Equity	₹0.01 Cr	0.04%
Tarsons Products Ltd	Equity	₹0.01 Cr	0.04%
Themis Medicare Ltd	Equity	₹0.01 Cr	0.04%
Kopran Ltd	Equity	₹0.01 Cr	0.04%
GPT Healthcare Ltd	Equity	₹0.01 Cr	0.03%
KMC Speciality Hospitals (India) Ltd	Equity	₹0.01 Cr	0.02%
Sastasundar Ventures Ltd	Equity	₹0 Cr	0.02%
NGL Fine-Chem Ltd	Equity	₹0 Cr	0.02%

Allocation By Market Cap (Equity)

Other Allocation

Equity Sector

Debt & Others

Sector	Amount	Holdings
Healthcare	₹25.22 Cr	98.41%
Basic Materials	₹0.15 Cr	0.57%

Risk & Performance Ratios

Fund Managers

Swapnil Mayekar

Since July 2022

Rakesh Shetty

Since November 2022

Dishant Mehta

Since October 2024

Additional Scheme Detailsas of 28th February 2025

ISIN

INF247L01BB1

Expense Ratio

0.22%

Exit Load

Fund Size

₹26 Cr

Age

2 years 7 months

Lumpsum Minimum

₹500

Fund Status

Open Ended Investment Company

Benchmark

BSE Healthcare TR INR

Investment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Capital Gains Taxation:

Dividend Taxation:

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Motilal Oswal S&P BSE Healthcare ETF Very High Risk	0.2%	-	₹25.63 Cr	20.0%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Very High Risk	1.1%	1.0%	₹754.75 Cr	13.4%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth Very High Risk	2.4%	1.0%	₹754.75 Cr	11.9%
Aditya Birla Sun Life Nifty Healthcare ETF Very High Risk	0.2%	-	₹37.95 Cr	15.9%
ITI Pharma and Healthcare Fund Direct Growth Very High Risk	0.5%	1.0%	₹200.83 Cr	19.0%
ITI Pharma and Healthcare Fund Regular Growth Very High Risk	2.4%	1.0%	₹200.83 Cr	16.8%
Mirae Asset Healthcare Fund Direct Growth Very High Risk	0.5%	1.0%	₹2441.13 Cr	19.9%
Mirae Asset Healthcare Fund Regular Growth Very High Risk	2.0%	1.0%	₹2441.13 Cr	18.2%
Nippon India Nifty Pharma ETF Very High Risk	0.2%	-	₹809.18 Cr	13.8%
Axis NIFTY Healthcare ETF Very High Risk	0.3%	-	₹17.44 Cr	15.8%

About the AMC

Motilal Oswal Mutual Fund

+91 22 39804263

https://www.motilaloswalmf.com/

Total AUM

₹88,086 Cr

Address

Motilal Oswal Tower, Mumbai, 400 025

Other Funds by Motilal Oswal Mutual Fund

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Motilal Oswal Small Cap Fund Direct Growth Very High Risk	0.4%	1.0%	₹3716.36 Cr	21.8%
Motilal Oswal Developed Market Ex US ETFs Fund of Funds Direct Growth Very High Risk	0.1%	1.0%	₹29.97 Cr	9.8%
Motilal Oswal Nifty Microcap 250 Index Fund Direct Growth Very High Risk	0.4%	1.0%	₹1672.87 Cr	9.5%
Motilal Oswal Ultra Short Term Fund Direct Growth Low to Moderate Risk	0.5%	0.0%	₹500.21 Cr	6.5%
Motilal Oswal S&P BSE Low Volatility Index Fund Direct Growth Very High Risk	0.4%	1.0%	₹102.40 Cr	1.6%
Motilal Oswal Nifty Next 50 Index Fund Direct Growth Very High Risk	0.4%	1.0%	₹270.39 Cr	6.3%
Motilal Oswal Nifty 50 Index Fund Direct Growth Very High Risk	0.1%	0.0%	₹577.73 Cr	7.7%
Motilal Oswal Large and Midcap Fund Direct Growth Very High Risk	0.6%	1.0%	₹7624.82 Cr	16.3%
Motilal Oswal S&P 500 Index Fund Direct Growth Very High Risk	0.6%	1.0%	₹3840.43 Cr	13.1%
Motilal Oswal Focused Fund Direct Growth Very High Risk	1.1%	1.0%	₹1306.57 Cr	-4.8%
Motilal Oswal Nasdaq 100 Fund of Fund Direct Growth Very High Risk	0.8%	1.0%	₹5529.07 Cr	21.7%
Motilal Oswal MSCI EAFE Top 100 Select Index Fund Direct Growth Very High Risk	0.5%	1.0%	₹35.75 Cr	12.4%
Motilal Oswal Midcap Fund Direct Growth Very High Risk	0.7%	1.0%	₹23703.68 Cr	19.3%
Motilal Oswal Nifty 200 Momentum 30 Index Fund Direct Growth Very High Risk	0.3%	1.0%	₹773.16 Cr	-6.3%
Motilal Oswal Equity Hybrid Fund Direct Growth Very High Risk	0.9%	1.0%	₹417.89 Cr	18.4%
Motilal Oswal Asset Allocation Passive Fund of Fund - Aggressive Direct Growth Very High Risk	1.7%	1.0%	₹71.67 Cr	11.0%
Motilal Oswal Asset Allocation Passive Fund of Fund - Conservative Direct Growth High Risk	1.6%	1.0%	₹44.69 Cr	11.0%
Motilal Oswal Multi Asset Fund Direct Growth High Risk	0.9%	1.0%	₹90.45 Cr	-7.0%
Motilal Oswal 5 Year G-Sec Fund of Fund Direct Growth Moderately High risk	0.4%	0.0%	₹33.29 Cr	8.7%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct Growth Very High Risk	0.4%	1.0%	₹702.04 Cr	6.0%
Motilal Oswal Nifty Midcap 150 Index Fund Direct Growth Very High Risk	0.3%	1.0%	₹1800.68 Cr	8.8%
Motilal Oswal Nifty Bank Index Fund Direct Growth Very High Risk	0.3%	1.0%	₹558.03 Cr	10.9%
Motilal Oswal Nifty 500 Fund Direct Growth Very High Risk	0.2%	1.0%	₹1906.88 Cr	7.2%
Motilal Oswal Long Term Equity Fund Direct Growth Very High Risk	0.7%	0.0%	₹3405.01 Cr	13.0%
Motilal Oswal Flexicap Fund Direct Growth Very High Risk	0.9%	1.0%	₹11171.69 Cr	20.4%
Motilal Oswal S&P BSE Enhanced Value Index Fund Direct Growth Very High Risk	0.5%	1.0%	₹696.52 Cr	5.7%
Motilal Oswal S&P BSE Quality Index Fund Direct Growth Very High Risk	0.4%	1.0%	₹40.20 Cr	2.0%
Motilal Oswal Liquid Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹991.01 Cr	6.9%
Motilal Oswal Gold and Silver ETFs Fund of Funds Direct Growth Very High Risk	0.1%	0.0%	₹244.32 Cr	31.5%
Motilal Oswal Balance Advantage Fund Direct Growth Very High Risk	1.0%	1.0%	₹890.56 Cr	-5.3%
Motilal Oswal S&P BSE Financials ex Bank 30 Index Fund Direct Growth Very High Risk	0.3%	1.0%	₹16.97 Cr	14.7%

Risk Level

Your principal amount will be at Very High Risk

Take control of your wealth

Track and Analyse all your investments with Wealth Monitor

Rated ★ 4.3+ on

Still got questions?
We're here to help.

What is the current NAV of Motilal Oswal S&P BSE Healthcare ETF?

The NAV of Motilal Oswal S&P BSE Healthcare ETF, as of 27-Mar-2025, is ₹41.86.

What is the portfolio composition of Motilal Oswal S&P BSE Healthcare ETF?

The fund's allocation of assets is distributed as 99.79% in equities, 0.00% in bonds, and 0.21% in cash and cash equivalents.

Who manages the Motilal Oswal S&P BSE Healthcare ETF?

The fund managers responsible for Motilal Oswal S&P BSE Healthcare ETF are:-

Swapnil Mayekar
Rakesh Shetty
Dishant Mehta

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme-related documents carefully. The NAVs of the schemes may go up or down depending upon the factors and forces affecting the securities market including the fluctuations in the interest rates. The past performance of the mutual funds is not necessarily indicative of the future performance of the schemes. Investors are requested to review the prospectus carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.

;

Fund Overview

Fund Size

₹26 Cr

Expense Ratio

0.22%

ISIN

INF247L01BB1

Minimum SIP

Exit Load

Inception Date

29 Jul 2022

Risk Level

Your principal amount will be at Very High Risk